Skida1tm1(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Skida1tm1(KOMP)Wtsi |
Name: |
SKI/DACH domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4841167 |
Gene: |
Skida1 Location: Chr2:18048510-18053627 bp, - strand Genetic Position: Chr2, 12.83 cM, cytoband A2
|
Alliance: |
Skida1tm1(KOMP)Wtsi page
|
IMPC: |
Skida1 gene page |
|
Mutant Cell Lines: |
EPD0296_3_A09, EPD0296_3_A10, EPD0296_3_A11, EPD0296_3_A12, EPD0296_3_B11, EPD0296_3_C09, EPD0296_3_D09, EPD0296_3_G09, EPD0296_3_G12, EPD0296_3_H09 |
Germline Transmission: |
Earliest citation of germline transmission:
J:211773
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 4394 starting at position 18048879 and ending at position 18053273 of Chromosome 2 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
6 reference(s) |
|